# Zafirlukast

NDC: 42291-971
Generic name: zafirlukast
Labeler / Manufacturer: AvKARE
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, COATED
Routes: ORAL
Marketing started: 20230405

FDA application: NDA020547

## Active ingredients

- ZAFIRLUKAST: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42291-971"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42291-971
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f89a821d-396f-a3aa-e053-6294a90a4577